The results of a clinical trial published in December in Molecular Psychiatry suggest that a new medication (NSI-189) which has been shown to increase the production of cells in the hippocampus and the amygdala in pre-clinical studies may help treat major depression. The results highlight the evidence that has been accumulating that stimulating the production of new cells in the hippocampus (neurogenesis) …